Quest Diagnostics SVP Patrick Plewman Acquires Shares via Dividend Reinvestment
QUEST DIAGNOSTICS INC
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Quest Diagnostics Inc ($DGX) Form 4 Alert Insider: Plewman Patrick (SVP for Diagnostic Services) Action: Acquired (DRIP) Shares: 41 @ $235.94 ($9,673.54 total value) Post Holdings: 15,334 shares (Direct) Significance: Low (Routine dividend reinvestment)
Comprehensive Analysis
Executive Summary
On October 23, 2026, Quest Diagnostics Inc ($DGX) reported a minor transaction by Patrick Plewman, Senior Vice President for Diagnostic Services. On October 21, 2026, Mr. Plewman acquired 41 shares of common stock at a price of $235.94 per share, totaling approximately $9,673.54.
Transaction Details
- Security: Common Stock
- Transaction Code: L (Small acquisition / Dividend Reinvestment Plan)
- Shares Acquired: 41
- Execution Price: $235.94
- Total Investment: $9,673.54
- Ownership Post-Transaction: 15,334 shares held directly
Filing Context & Significance
This transaction represents an automatic acquisition pursuant to a broker-administered dividend reinvestment plan (DRIP). Per Rule 16a-6, such transactions are typically eligible for deferred reporting on Form 5; however, the reporting person elected early voluntary disclosure on Form 4. Given that this is a routine, non-discretionary acquisition of negligible size relative to total holdings, it carries minimal market significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.